NCT04255134View on ClinicalTrials.gov

Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 7, 2020

Primary Completion Date

October 26, 2022

Study Completion Date

October 26, 2022

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Abatacept Injection

Subjects will be randomized to treatment with either abatacept or adalimumab

DRUG

Adalimumab Injection

Subjects will be randomized to treatment with either abatacept or adalimumab

Trial Locations (1)

SW17 OPQ

Hotung Centre for Musculoskeletal Diseases, London

All Listed Sponsors
lead

St George's, University of London

OTHER

NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) | Biotech Hunter | Biotech Hunter